DK0580008T3 - Phenylimidazolidin-derivater, deres fremstilling og deres anvendelse - Google Patents

Phenylimidazolidin-derivater, deres fremstilling og deres anvendelse

Info

Publication number
DK0580008T3
DK0580008T3 DK93110754T DK93110754T DK0580008T3 DK 0580008 T3 DK0580008 T3 DK 0580008T3 DK 93110754 T DK93110754 T DK 93110754T DK 93110754 T DK93110754 T DK 93110754T DK 0580008 T3 DK0580008 T3 DK 0580008T3
Authority
DK
Denmark
Prior art keywords
preparation
phenylimidazolidine
derivatives
phenylimidazolidine derivatives
nhr
Prior art date
Application number
DK93110754T
Other languages
Danish (da)
English (en)
Inventor
Gerhard Dr Zoller
Bernd Dr Jablonka
Melitta Dr Just
Otmar Dr Klingler
Gerhard Dr Breipohl
Jochen Dr Knolle
Wolfgang Dr Koenig
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0580008T3 publication Critical patent/DK0580008T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/40—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK93110754T 1992-07-24 1993-07-06 Phenylimidazolidin-derivater, deres fremstilling og deres anvendelse DK0580008T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4224414A DE4224414A1 (de) 1992-07-24 1992-07-24 Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
DK0580008T3 true DK0580008T3 (da) 1999-02-08

Family

ID=6463969

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93110754T DK0580008T3 (da) 1992-07-24 1993-07-06 Phenylimidazolidin-derivater, deres fremstilling og deres anvendelse

Country Status (16)

Country Link
US (1) US5424293A (ko)
EP (1) EP0580008B1 (ko)
JP (1) JP3775808B2 (ko)
KR (1) KR100418321B1 (ko)
AT (1) ATE168116T1 (ko)
AU (1) AU664630B2 (ko)
CA (1) CA2101179C (ko)
CZ (1) CZ289297B6 (ko)
DE (2) DE4224414A1 (ko)
DK (1) DK0580008T3 (ko)
ES (1) ES2119837T3 (ko)
HU (1) HU220767B1 (ko)
IL (1) IL106462A (ko)
SK (1) SK282517B6 (ko)
TW (1) TW306918B (ko)
ZA (1) ZA935341B (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4308034A1 (de) * 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
DE4427979A1 (de) 1993-11-15 1996-02-15 Cassella Ag Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5563158A (en) * 1993-12-28 1996-10-08 The Dupont Merck Pharmaceutical Company Aromatic compounds containing basic and acidic termini useful as fibrinogen receptor antagonists
ZA963391B (en) * 1995-05-24 1997-10-29 Du Pont Merck Pharma Isoxazoline fibrinogen receptor antagonists.
ES2171768T3 (es) 1996-03-20 2002-09-16 Hoechst Ag Inhibidores de la resorcion osea y antagonistas de receptores de vitronectina.
DE19622489A1 (de) 1996-06-05 1997-12-11 Hoechst Ag Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters
DE19647381A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19647380A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19647382A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19741235A1 (de) * 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de) 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
DE19821483A1 (de) 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US6163155A (en) * 1999-01-28 2000-12-19 Dresser Industries, Inc. Electromagnetic wave resistivity tool having a tilted antenna for determining the horizontal and vertical resistivities and relative dip angle in anisotropic earth formations
DE19922462A1 (de) 1999-05-17 2000-11-23 Aventis Pharma Gmbh Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate
EP1183274A1 (en) * 1999-06-17 2002-03-06 Source Precision Medicine, Inc. Method and compounds for inhibiting activity of serine elastases
DE10111877A1 (de) 2001-03-10 2002-09-12 Aventis Pharma Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10137595A1 (de) * 2001-08-01 2003-02-13 Aventis Pharma Gmbh Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung
CA2655200C (en) 2006-07-11 2013-12-03 Halliburton Energy Services, Inc. Modular geosteering tool assembly
AU2007273026B2 (en) * 2006-07-12 2010-04-08 Halliburton Energy Services, Inc. Method and apparatus for building a tilted antenna
GB2459067B (en) * 2007-03-16 2011-11-30 Halliburton Energy Serv Inc Robust inversion systems and methods for azimuthally sensitive resistivity logging tools
BRPI0822137B1 (pt) 2008-12-16 2018-10-09 Halliburton Energy Serv Inc conjunto de fundo de furo, e, método de perfilagem
MY177675A (en) 2010-01-22 2020-09-23 Halliburton Energy Services Inc Method and apparatus for resistivity measurements
AU2012383577B2 (en) 2012-06-25 2015-07-09 Halliburton Energy Services, Inc. Tilted antenna logging systems and methods yielding robust measurement signals
WO2016172496A1 (en) 2015-04-23 2016-10-27 Constellation Pharmaceuticals, Inc. Lsd1 inhibitors and uses thereof
FI3532459T3 (fi) 2016-10-26 2023-10-23 Constellation Pharmaceuticals Inc Lsd1-estäjiä ja niiden lääkinnällisiä käyttöjä

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4126277A1 (de) * 1991-08-08 1993-02-11 Cassella Ag Hydantoinderivate
DE4213634A1 (de) * 1992-04-24 1993-10-28 Cassella Ag 2,4-Dioxo-imidazolidin-Derivate

Also Published As

Publication number Publication date
DE4224414A1 (de) 1994-01-27
AU664630B2 (en) 1995-11-23
IL106462A (en) 1997-02-18
US5424293A (en) 1995-06-13
EP0580008A2 (de) 1994-01-26
HUT65141A (en) 1994-04-28
CA2101179C (en) 2003-10-28
KR100418321B1 (ko) 2004-05-07
CA2101179A1 (en) 1994-01-25
TW306918B (ko) 1997-06-01
ES2119837T3 (es) 1998-10-16
EP0580008B1 (de) 1998-07-08
DE59308732D1 (de) 1998-08-13
ATE168116T1 (de) 1998-07-15
JP3775808B2 (ja) 2006-05-17
SK76993A3 (en) 1994-04-06
CZ147593A3 (en) 1994-03-16
KR940005583A (ko) 1994-03-21
AU4211993A (en) 1994-01-27
CZ289297B6 (cs) 2001-12-12
JPH0725855A (ja) 1995-01-27
HU9302138D0 (en) 1993-10-28
ZA935341B (en) 1994-02-14
IL106462A0 (en) 1993-11-15
EP0580008A3 (de) 1995-03-15
HU220767B1 (hu) 2002-05-28
SK282517B6 (sk) 2002-10-08

Similar Documents

Publication Publication Date Title
DK0580008T3 (da) Phenylimidazolidin-derivater, deres fremstilling og deres anvendelse
BG100951A (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
HU9203948D0 (en) Piperazinyl-cyclohexanones and piperidinyl ones
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
NO903952L (no) Fremgangsmaate for fremstilling av aminosyrederivater med reninhemmende egenskaper, og anvendelse av midler som inneholder disse.
IL83141A0 (en) Solutions of oxazophorins having improved stability and their preparation
DK353282A (da) Heterocyclisk substituerede sulfonylurinstoffer,deres fremstilling og anvendelse i herbicider og vaekstregulerende midler
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DK192988A (da) Dihydropyridinamider, deres fremstilling og anvendelse
DK282285A (da) Hidtil ukendte 8-alkylthio-2-piperazino-pyrimido(5,4-d)pyrimidiner,deres fremstilling og laegemidler indeholdende disse forbindelser
DK640687A (da) Allylmercaptoacetylsydnoniminer, deres fremstilling og anvendelse
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
NO984921L (no) Tienopyridinderivater og deres anvendelser
DK522889A (da) Substituerede 3-aminosydnoniminer og farmakologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
PL312966A1 (en) Derivatives of thiocarbamoil
AU4370489A (en) The use of oxidized polyamines, especially nn'-bis-(3- propionaldehyde)-1-4-diaminobutane (sperminedialdehyde) as immunosuppressive agents
ZA874596B (en) 3-substituted 1-(2-halogenoalkoxy-benzenesulphonyl)-3-heteroaryl-(thio)ureas
DK0429751T3 (da) Substituerede 3-aminosydnoniminer, fremgangsmåde til deres fremstilling og deres anvendelse
NO20010332L (no) Nye derivater av 6-deoksyerytromycin, deres fremstillingsprosess og deres anvendelse som medikamenter